Tools

LEADER 03617nam a2200589 i 4500

001 on1461584287;

003 OCoLC;

005 20250120152034.0;

006 m o d f ;

007 cr |||||||||||;

008 241016s2024 dcuab ob f000 0 eng c;

024 8 a| 56-048q| (GPO jacket number);

035 a| (Sirsi) o1461584287;

042 a| pcc;

043 a| n-us---a| a-cc---;

049 a| ERE#;

074 a| 1037-D (online);

086 0 a| Y 4.G 74/9:S.HRG.118-355;

245 10 a| Origins of COVID-19 :b| an examination of available evidence : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, second session, June 18, 2024.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2024.;

300 a| 1 online resource (iv, 1,152 pages) :b| color illustrations, color maps.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| S. hrg. ;v| 118-355;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Gregory D. Koblentz, Ph.D., Associate Professor and Director, Biodefense Graduate Program, George Mason University; Robert F. Garry, Ph.D., Professor and Associate Dean, School of Medicine, Tulane University; Steven C. Quay, M.D., Ph.D., Chief Executive Officer, Atossa Therapeutics, Inc., Former Faculty Member, Stanford University School of Medicine; Richard H. Ebright, Ph.D., Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology, Rutgers University.;

518 a| Date of hearing: 2024-06-18.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed Oct. 16, 2024).;

650 7 a| Health.2| cgpa;

650 7 a| Government Operations and Politics.2| cgpa;

650 0 a| COVID-19 (Disease)z| United States.=| ^A1407776;

650 0 a| COVID-19 (Disease)z| Chinaz| Wuhan Shi.=| ^A1407776;

610 20 a| Zhongguo ke xue yuan.b| Wuhan bing du yan jiu suo.0| https://id.loc.gov/authorities/names/n83218093=| ^A1416157;

650 0 a| COVID-19 (Disease)x| Etiology.=| ^A1407776;

650 0 a| COVID-19 Pandemic, 2020-2023z| United States.=| ^A1418885;

650 0 a| COVID-19 (Disease)x| Political aspectsz| United States.=| ^A1407776;

650 0 a| National securityz| United States.0| https://id.loc.gov/authorities/subjects/sh85140387=| ^A273467;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs.t| Origins of COVID-19w| (OCoLC)1461584081;

856 40 u| https://purl.fdlp.gov/GPO/gpo2338907| 0;

922 a| BIBCONEWb| 20241016;

922 a| PUBPOLTERMSb| 20241016;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6493023;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6493023-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 11/7/2024x| EDOCUMENTz| JERESOURCE;

Origins of COVID-19 : an examination of available evidence : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, second session, June 18, 2024.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2024.
Description	1 online resource (iv, 1,152 pages) : color illustrations, color maps.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo233890
Subjects	Zhongguo ke xue yuan. Wuhan bing du yan jiu suo. COVID-19 (Disease)--United States. COVID-19 (Disease)--China. --Wuhan Shi. COVID-19 (Disease)--Etiology. COVID-19 Pandemic, 2020-2023--United States. COVID-19 (Disease)--Political aspects. --United States. National security--United States.

Series	S. hrg. ; 118-355 United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 118-355. ^A500722
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Gregory D. Koblentz, Ph.D., Associate Professor and Director, Biodefense Graduate Program, George Mason University; Robert F. Garry, Ph.D., Professor and Associate Dean, School of Medicine, Tulane University; Steven C. Quay, M.D., Ph.D., Chief Executive Officer, Atossa Therapeutics, Inc., Former Faculty Member, Stanford University School of Medicine; Richard H. Ebright, Ph.D., Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology, Rutgers University.
Date/time/place of a event note	Date of hearing: 2024-06-18.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed Oct. 16, 2024).
Issued in other form	Print version: United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Origins of COVID-19
Genre/form	Legislative hearings.
Standard identifier#	56-048 (GPO jacket number)
GPO item number	1037-D (online)
Govt. docs number	Y 4.G 74/9:S.HRG.118-355

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Origins of COVID-19 : an examination of available evidence : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, second session, June 18, 2024.

Click here for more information about this title

Availability